首页|期刊导航|中华医学杂志（英文版）|Outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus efavirenz-based regimens in central China:a real-world assessment

Outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus efavirenz-based regimens in central China:a real-world assessment

Yongquan Peng Xujian Cao Yating Wang Weiwei Yu Ziwei Zeng Min Wang

中华医学杂志（英文版）2023，Vol.136Issue(22)：2738-2740,3.

中华医学杂志（英文版）2023，Vol.136Issue(22)：2738-2740,3.DOI:10.1097/CM9.0000000000002888

Outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus efavirenz-based regimens in central China:a real-world assessment

Yongquan Peng ¹Xujian Cao ¹Yating Wang ¹Weiwei Yu ²Ziwei Zeng ²Min Wang²

作者信息

1. Graduate Collaborative Training Base of the First Hospital of Changsha,University of South China,Hengyang,Hunan 421001,China
2. Institute of HIV/AIDS,First Hospital of Changsha,Changsha,Hunan 410000,China
折叠

摘要

引用本文复制引用

Yongquan Peng,Xujian Cao,Yating Wang,Weiwei Yu,Ziwei Zeng,Min Wang..Outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus efavirenz-based regimens in central China:a real-world assessment[J].中华医学杂志（英文版）,2023,136(22):2738-2740,3.

基金项目

This work was partially supported by the Research project of Hunan Provincial Department of Science and Technology(No.2020SK21361). （No.2020SK21361）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航